BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and ...

Three-quarters of pharma and life sciences executives said they were optimistic for 2025, even though they expect some level ...

So-called mirror cells could rampage through our ecosystems, food supply and immune systems, experts say, potentially without ...

According to market observers, shares of the company are available at a premium of ₹18 in the grey market today ...

While Chicago's life-sciences vacancy remains elevated heading into 2025, capital market trends and a growing appetite for ...

Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical ...

In an exclusive interview, an expert in Unispace's Life Sciences growth strategy across the Americas, offers his perspective ...

Sai Life Sciences IPO price band is fixed at ₹522 to ₹549 per share. At the upper-end of the price band, the company plans to ...

Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension ...

Sai Life Sciences Ltd's Rs 3,043-crore IPO saw a remarkable 10.26 times subscription on the final day. The company's shares ...

Sai Life Sciences Ltd.'s initial public offering entered its final day for subscription on Friday. It was subscribed 1.65 ...

TPG Capital-backed Sai Life Sciences IPO closes with 1.25x subscription, offering fresh issue and stake sale. Market lot: 27 ...